LivingGLP1
Study S001095

The Effect of Liraglutide on Pancreatic Hormones and Its Size

ClinicalTrials.gov record

Registration

Registration
NCT03520062
Acronym
LIRAP
Study type
INTERVENTIONAL
Masking
NONE
Status
COMPLETED
Enrollment
14
Start
2017-08-15
Primary completion
2019-04-30
Lead sponsor
Nicolai Jacob Wewer Albrechtsen
Conditions
Obesity
Interventions
DRUG:Liraglutide (Saxenda) 6Mg/Ml Inj Pen 3Ml
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • Volumetric Changes of the Pancreas [6 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.